Updates in Diagnosis, Treatment, and Management of Metastatic Uveal Melanoma - Episode 3
An expert provides an overview of the historical and currently available treatment options in metastatic uveal melanoma (mUM), including the bispecific T-cell receptor immunotherapy tebentafusp (“teh-BEN-tah-fuhsp”).
Direct-to-Bladder Immunotherapy Drug to Be Studied in Bladder Cancer
Chemo Combo Adds More to the Treatment Toolbox for Advanced Pancreatic NETs
Anniversary Time: A Look Back of What I’ve Learned 10 Years After Cancer
Taking 8-Plus Medications Before Cancer Treatment May Affect Effectiveness in Older Patients